Virus therapy takes on tough cancers in early trial
Disease control
Recruiting now
This early-phase study is testing a modified virus called OTS-412, given alone or with hydroxyurea and the immunotherapy atezolizumab, in 27 adults with solid tumors that have stopped responding to standard treatments. The main goal is to check safety and side effects, while also…
Phase: PHASE1 • Sponsor: Bionoxx Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC